SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meyer Christian

(Last)

(First)

(Middle)

C/O UNIQURE N.V.

MEIBERGDREFF 61

(Street)

AMSTERDAM

1005 BA

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2017

3. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Performance Share Units	⁽¹⁾	⁽²⁾	Ordinary Shares	12,000	$0	D
Stock Option (right to buy)	⁽³⁾	01/28/2026	Ordinary Shares	20,000	$18.21	D
Stock Option (right to buy)	⁽⁴⁾	05/27/2024	Ordinary Shares	50,000	$9.35	D
Stock Option (right to buy)	⁽⁵⁾	01/09/2023	Ordinary Shares	140,652	⁽⁶⁾	D

Explanation of Responses:

1. Performance Share Units of a maximum of 12,000 shares of the Company's Ordinary Shares were granted on January 28, 2016. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2019.

2. Expiration date is not applicable.

3. The Stock Option vests 25% on January 28, 2017 and 6.25% quarterly thereafter until fully vested.

4. The Stock Option vests 25% on May 27, 2015 and 6.25% quarterly thereafter until fully vested.

5. The Stock Option is fully vested.

6. The Stock Option is exercisable at a price of ?3.07 per share ($3.23, as converted.) The conversion from Euro (?) into U.S. dollars ($) applied the exchange rate as of December 30, 2016 of ?1 to $1.0541.

Remarks:

See Exhibit 24 - Power of Attorney

	/s/Lauren M. Watson, Attorney-in-Fact	01/06/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.